Connection
Sunad Rangarajan to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Sunad Rangarajan has written about Clinical Trials, Phase II as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.139 |
|
|
|
-
Rangarajan S, Locy ML, Luckhardt TR, Thannickal VJ. Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now? Drugs. 2016 Mar; 76(3):291-300.
Score: 0.139